Solid Dispersion Platform™ Overview

Agere’s Solid Dispersion Platform™ is a predictive, mechanistic-based approach to the development of amorphous molecular dispersions of API and polymer excipients. The Solid Dispersion Platform™ provides pre-formulation and formulation development of promising chemical matter that has solubility-limited absorption. This can greatly enhance oral bioavailability relative to crystalline or unformulated drug.

The Solid Dispersion Platform™ is now available through through a low-cost, zero-entanglement fee-for-service business model.